Federal Register / Vol. 63, No. 132 / Friday, July 10, 1998 / Notices 37383

formal comment letter was sent to the

preparing agency.

Dated: July 7, 1998.

William D. Dickerson,

Director, NEPA Compliance Division, Office

of Federal Activities.

[FR Doc. 98–18440 Filed 7–9–98; 8:45 am]

BILLING CODE 6560–50–P

FEDERAL DEPOSIT INSURANCE

CORPORATION

Sunshine Act Meeting

Pursuant to the provisions of the

‘‘Government in the Sunshine Act’’ (5

U.S.C. 552b), notice is hereby given that

at 11:02 a.m. on Tuesday, July 7, 1998,

the Board of Directors of the Federal

Deposit Insurance Corporation met in

closed session to consider matters

relating to the Corporation’s supervisory

activities.

In calling the meeting, the Board

determined, on motion of Vice

Chairman Andrew C. Hove, Jr.,

seconded by Director Ellen S. Seidman

(Director, Office of Thrift Supervision),

concurred in by Director Julie L.

Williams (Acting Comptroller of the

Currency), Director Joseph H. Neely

(Appointive), and Chairman Donna

Tanoue, that Corporation business

required its consideration of the matters

on less than seven days’ notice to the

public; that no earlier notice of the

meeting was practicable; that the public

interest did not require consideration of

the matters in a meeting open to public

observation; and that the matters could

be considered in a closed meeting by

authority of subsections (c)(4), (c)(6),

(c)(8), and (c)(9)(A)(ii) of the

‘‘Government in the Sunshine Act’’ (5

U.S.C. 552b(c)(4), (c)(6), (c)(8), and

(c)(9)(A)(ii)).

The meeting was held in the Board

Room of the FDIC Building located at

550—17th Street, N.W., Washington,

D.C.

Dated: July 7, 1998.

Federal Deposit Insurance Corporation.

James D. LaPierre,

Deputy Executive Secretary.

[FR Doc. 98–18520 Filed 7–7–98; 5:02 pm]

BILLING CODE 6714–01–M

FEDERAL HOUSING FINANCE BOARD

Sunshine Act Meeting

FEDERAL REGISTER CITATION OF PREVIOUS

ANNOUNCEMENT: 63 FR 36691, July 7,

1998.

PREVIOUSLY ANNOUNCED TIME AND DATE OF

THE MEETING: 10:00 A.M., Wednesday,

July 8, 1998.

CANCELLATION OF THE MEETING: Notice is

hereby given of the cancellation of the

Board of Directors meeting scheduled

for July 8, 1998.

CONTACT PERSON FOR MORE INFORMATION:

Elaine L. Baker, Secretary to the Board,

(202) 408–2837.

William W. Ginsberg,

Managing Director.

[FR Doc. 98–18472 Filed 7–7–98; 4:50 pm]

BILLING CODE 6725–01–P

FEDERAL RESERVE SYSTEM

Agency Information Collection

Activities: Announcement of Board

Approval Under Delegated Authority

and Submission to OMB

SUMMARY

Background. Notice is hereby given of

the final approval of a proposed

information collection by the Board of

Governors of the Federal Reserve

System (Board) under OMB delegated

authority, as per 5 CFR 1320.16 (OMB

Regulations on Controlling Paperwork

Burdens on the Public). Board-approved

collections of information are

incorporated into the official OMB

inventory of currently approved

collections of information. Copies of the

OMB 83-Is and supporting statements

and approved collection of information

instrument are placed into OMB’s

public docket files. The Federal Reserve

may not conduct or sponsor, and the

respondent is not required to respond

to, an information collection that has

been extended, revised, or implemented

on or after October 1, 1995, unless it

displays a currently valid OMB control

number.

FOR FURTHER INFORMATION CONTACT:

Chief, Financial Reports Section—Mary

M. McLaughlin—Division of Research

and Statistics, Board of Governors of

the Federal Reserve System,

Washington, DC 20551 (202-452-3829)

OMB Desk Officer—Alexander T.

Hunt—Office of Information and

Regulatory Affairs, Office of

Management and Budget, New

Executive Office Building, Room

3208, Washington, DC 20503 (202-

395-7860)

Final approval under OMB delegated

authority of the extension for three

years, without revision, of the following

report:

1. Report title: Ongoing Intermittent

Survey of Households

Agency form number: FR 3016

OMB Control number: 7100-0150

Effective Date: August 10, 1998.

Frequency: on occasion

Reporters: households and

individuals

Annual reporting hours: 130 burden

hours

Estimated average hours per response:

3.12 minutes

Number of respondents: 500

Small businesses are not affected.

General description of report: This

information collection is voluntary (12

U.S.C. 225a, 263, and 15 U.S.C. 1691b)

and is given confidential treatment (5

U.S.C. 552(b)(6)).

Abstract: The Federal Reserve uses

this voluntary survey to obtain

household-based information

specifically tailored to the Federal

Reserve’s policy, regulatory, and

operational responsibilities, and the

survey is necessary to provide

information on developing events in the

financial markets. Intermittently, on

request, the University of Michigan’s

Survey Research Center includes survey

questions on behalf of the Federal

Reserve in an addendum to their regular

monthly Survey of Consumer Attitudes

and Expectations. The frequency and

content of the questions depends on

changing economic and legal

developments.

Board of Governors of the Federal Reserve

System, July 6, 1998

Jennifer J. Johnson

Secretary of the Board.

[FR Doc. 98–18409 Filed 7–9–98; 8:45AM]

Billing Code 6210–01–F

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

[Announcement 98098]

Technology Translation and Transfer

of Effective HIV Prevention

Interventions; Notice of Availability of

Funds

A. Purpose

The Centers for Disease Control and

Prevention (CDC) announces the

availability of fiscal year (FY) 1998

funds for a cooperative agreement

program for the technology translation

and transfer of effective HIV prevention

interventions. This program addresses

the ‘‘Healthy People 2000’’ priority area

of Human Immunodeficiency Virus

(HIV) Infection.

In order to slow the spread of HIV/

AIDS, researchers have developed and

tested prevention interventions that aim

to reduce sex-related and drug-related
37384 Federal Register / Vol. 63, No. 132 / Friday, July 10, 1998 / Notices

risk behaviors. As a result of these

studies, a number of interventions with

credible evidence of effectiveness have

been identified. This project will be a

case study of the translation and transfer

of an effective intervention in a nonresearch setting.

The purpose of this project is to

enhance access to and use of effective

interventions by service providers

nationwide. Recipients will develop

prevention packages that are readily

useable by service providers. Recipients

will develop prevention packages and

refine them as they are piloted in the

field setting. This will serve as a case

study of the technology transfer process.

The specific purposes of this program

are to: (1) Translate an individual or

small group HIV prevention

intervention (especially those targeted

to persons at increased risk of HIV

infection) with credible evidence of

effectiveness, i.e., an effective

intervention. This first activity is to be

done in collaboration with health

departments, community-based

organizations, or other service delivery

providers who can provide feedback

and advice; (2) Develop a prevention

package that includes training materials

and technical assistance protocols as

well as the intervention itself; and (3)

Study the process of technology

transfer, using the prevention package

in a field setting.

B. Eligible Applicants

Applications may be submitted by

public and private nonprofit and forprofit organizations and governments

and their agencies. Thus, universities,

colleges, research institutions, hospitals,

other public and private organizations,

State and local health departments or

their bona fide agents, federally

recognized Indian tribal governments,

Indian tribes or Indian tribal

organizations.

However, since the purpose of this

technology translation and transfer

project is to build on successful research

projects, applicants must clearly

demonstrate that their intervention has

been tested under rigorous study design

criteria (including the use of a control

or comparison group) and found to be

effective with significant positive results

for changing HIV risk behavior. The

applicant must have evidence that a

report on this effective intervention has

been submitted for publication or has

been published in a peer-reviewed

journal.

Note: Public Law 104–65 states that an

organization described in section 501(c)(4) of

the Internal Revenue Code of 1986 that

engages in lobbying activities is not eligible

to receive Federal funds constituting an

award, grant, cooperative agreement,

contract, loan, or any other form.

C. Availability of Funds

Approximately $400,000 is available

in FY 1998 to fund approximately 2

awards. It is expected that the average

award will be $190,000, ranging from

$180,000 to $200,000. It is expected that

the awards will begin on or about

September 30, 1998, and will be made

for a 12-month budget period within a

project period of 2 years. Funding

estimates may vary and are subject to

change based on availability of funds.

An application requesting greater than

$200,000 will not be considered for

review and will be returned to the

applicant.

Continuation awards within an

approved project period will be made

on the basis of satisfactory progress as

evidenced by required reports and the

availability of funds. Continued funding

for year 2 will be dependent on the

completion of required activities for

year 1. Applicants should anticipate

that a portion of year 2 funding may be

used in the field setting (approximately

$20,000) as needed to implement the

program.

Use of Funds

Collection of new or supplemental

intervention research data, data entry

and analysis, purchase of furniture or

computers, and rental of facilities will

not be funded under this program.

D. Program Requirements

In conducting activities to achieve the

purpose of this announcement, the

recipient will be responsible for the

activities under 1, Recipient Activities,

and CDC will be responsible for the

activities listed under 2, CDC Activities.

1. Recipient Activities

a. Develop the intervention portion of

the prevention package.

(1) The recipient will develop the

package in collaboration with

representatives of HIV prevention

service delivery programs, e.g., health

departments, community-based

organizations (CBOs).

(2) Prevention packages should

include:

(a) Language and format that are

understandable and attractive to service

providers who are nonresearchers.

(b) A full description of the

intervention, including the background

and the target population.

(c) A list and description of the core

elements for the pre-implementation,

implementation, and maintenance

phases.

(d) Protocols for implementing the

intervention and ensuring its quality

and consistency.

(e) Specific guidelines for overcoming

barriers to implementation.

(f) A list of all staff, facility, and

material resources needed to conduct

the intervention, including level of staff

skill and time commitment, and cost

breakdowns.

(g) A time line of specific steps for

setting up the intervention.

(h) A bibliography of publications

based on the intervention.

b. Develop the training and technical

assistance portion of the prevention

package.

(1) The recipient should develop

training materials that can be used in

preparing providers to use the

prevention package. These materials

will assist the user with preimplementation and implementation

tasks necessary to undertake the

intervention during year 2. The

materials should emphasize experiential

learning and other active methods

associated with skill building.

(2) The recipient should develop an

outline for providing technical

assistance which identifies the likely

technical assistance requests that users

may make and an appropriate response

for each request.

c. Produce a limited number of draft

prevention packages.

The recipient will produce draft

packages using less costly materials

than those to be used in the final

product, but without changing the

overall effect, e.g., less heavy stock

paper for binding covers but with same

logo or design, notebook rather than

bound.

d. Identify an organization or field

setting for case study.

(1) Compile a list of HIV prevention

service agencies in the recipient’s state

or within close proximity to the

recipient’s city which target populations

for whom the intervention is

appropriate (for this announcement,

such agencies will be referred to as

potential users);

(2) Create approaches to establish

linkages with the potential users and

strategies to market the prevention

package to them.

(3) Select ways to inform potential

users who express interest about the

availability of a case study experience.

(4) Develop a written agreement with

the organization selected for the case

study (for this announcement, such

organization will be referred to as the

user).

e. Develop the evaluation plan.

(1) Data should be both quantitative

and qualitative and should include
Federal Register / Vol. 63, No. 132 / Friday, July 10, 1998 / Notices 37385

observations and reports that permit

assessment of the fit between the:

(a) core elements specified in the

prevention package and the content of

the implementation.

(b) methods specified in the

prevention package and the delivery of

the intervention, but no behavioral or

health outcomes data should be

collected.

(2) Process data should include

observations and reports of:

(a) barriers to implementation and

how they impacted the case study

(b) solutions to barriers

(c) cost containment strategies.

During the second year, the recipient

will complete the development of

training materials, technical assistance

outlines, and process evaluation

protocols necessary to initiate the case

study. Data collection will take place

throughout the case study or for

approximately 6 months (based on an

estimated delivery of one program per

week). The final three months of the

project will be used to analyze the

process data and refine the prevention

package.

2. CDC Activities.

a. Host a meeting with the successful

applicants within 60 days of the notice

of grant award to discuss

implementation of the project.

b. Provide technical assistance in the

general operation of this HIV prevention

project.

c. Consult on the choice of user for a

case study with the prevention package.

d. Monitor and evaluate scientific and

operational accomplishments of this

project through frequent telephone

contact and review of technical reports

and interim data analyses.

e. Conduct site visits to assess

program progress and mutually solve

problems, as needed.

f. At the end of the two year project,

CDC, in addition to the authors, may

distribute the package.

E. Application Content

Develop applications in accordance

with PHS Form 5161–1 (OMB Number

0937–0189) and the instructions and

format provided below.

Submit the original and two copies of

PHS Form 5161–1 (OMB Number 0937–

0189) and the original and two copies of

the application. The application may

not exceed 20 double-spaced pages,

excluding abstract, index, and

appendices. Submit the original and

each copy of the application

UNSTAPLED and UNBOUND. Print all

material double-spaced, in a 12-point or

larger font size on 81⁄2’’ by 11’’ paper,

with at least 1’’ margins, and printed on

one side only. Provide a one-page

abstract of the proposal and a complete

index to the application and its

appendices. Beginning with the first

page of text, number all pages clearly

and sequentially. Number each page of

the appendices also, e.g., for Appendix

#1, the pages should be numbered: A1–

1, A1–2, A1–3. Replace double-sided

article reprints with a one-sided copy.

Include a general introduction,

followed by one narrative subsection for

each of the numbered content elements

per application, in the order in which

the elements appear below. Label each

narrative subsection with the element

title and include all the information

needed to evaluate that element of the

application (except for curriculum vitae,

references, and letters of support, which

are appropriate for the appendices). The

application content elements are:

1. Effective intervention

a. Identify the principal investigator(s)

and name and location of the

agency(ies) that originally developed,

conducted, and evaluated the small

group or individual level intervention

research.

b. Provide written permission from

the original developers of the

intervention to develop and market

materials that may be original or derived

for the prevention package.

c. Describe the study’s positive results

on behavioral or health outcomes,

including how these results are both

statistically and practically significant.

d. Include in the appendix, a copy of

any reports that describe the study

design and the positive behavioral or

health outcomes of a small group or

individual level intervention that have

been submitted for publication or

published in peer reviewed journals.

This portion of the appendix should be

labeled as ‘‘Intervention Study Design

and Results.’’

e. Substantiate the need for a

prevention package in terms of risk of

target population and potential for

generalizability to other target groups.

f. Describe the feasibility of

implementation by other organizations,

particularly those with limited

resources.

2. Prevention package

a. Describe the prevention package.

Include descriptions of:

(1) Target populations for whom the

intervention would be appropriate;

(2) Pre-implementation phase,

including specific steps for setting up

the intervention, necessary

collaborators, necessary materials, other

resources, staff commitment (numbers

and time) and skills for conducting the

intervention, and training materials;

(3) Implementation phase, including

protocols for implementing the

intervention and ensuring quality and

consistency and providing technical

assistance, identification of barriers to

implementation and how they may be

overcome, and process evaluation

methods; and

(4) Maintenance phase, including how

to deal with issues of staff turnover and

retraining.

b. Explain how staff from HIV

prevention programs (e.g., health

departments and CBOs) within the

applicant’s state or within close

proximity to the applicant’s home city

will be involved in the development of

the package. Describe the planned

procedures for how these collaborators

will be identified.

c. Present a time line for developing

the prevention package.

3. Field site for implementation of the

package in year two (2)

a. Discuss a plan to identify and

recruit potential users within your state

or within close proximity to your home

city and indicate any which already

have shown interest in or may be

interested in implementing this

intervention.

b. Elaborate on the criteria and

mechanism for selecting the user(s) who

will implement the package.

Note: The agency that originally conducted

the intervention is excluded from

consideration as a potential user, as is any

agency that currently or previously

implemented the intervention.

4. Strategy to assist implementation

a. Describe the strategy to facilitate

implementation of the package,

including provision of training and

direct technical assistance from the

recipient to the selected user(s).

b. Discuss procedures to involve

user(s) in implementing the package,

including use of user’s existing staff and

resources, and to identify barriers to

implementation and how to overcome

them. Feasibility and sustainability of

the intervention with existing resources

are important for the successful

adoption and maintenance of the

package.

5. Plan to evaluate the implementation

process

Describe the plan for evaluating the

process of implementing the prevention

package. The plan should address

(unless not applicable): (1) methods, (2)

quality assurance monitoring of

intervention delivery including

documentation of intervention episodes,

(3) employee recruitment and retention,

(4) participant recruitment, (5) accuracy
37386 Federal Register / Vol. 63, No. 132 / Friday, July 10, 1998 / Notices

and completeness of record keeping,

and (6) costs of intervention delivery.

6. Capacity

a. Demonstrate capacity to conduct

the proposed activities including the

process evaluation.

b. Describe the proposed staffing,

show percentages of each staff member’s

commitment to this and other projects,

and division of duties and

responsibilities for this project; include

brief position descriptions for existing

and proposed personnel.

c. Demonstrate that the staff have the

expertise to complete this project,

including ability to produce the

intervention product(s). Demonstration

of this capability would include

examples of previously developed fact

sheets, web sites, or samples from other

intervention packages.

d. Name the staff members who are

key to the completion of the project.

Provide a brief description of the

strengths each brings to this project.

Include their curriculum vitae in the

appendix.

e. Describe access to graphics

expertise for production and editing of

the intervention package.

f. Describe equipment and facilities to

be used for the proposed activities.

7. Budget

Provide a detailed, line-item budget

for the project; justify each line-item,

including the need for any proposed

consultants and contractors. Plan for at

least two trips to Atlanta to meet with

CDC representatives.

F. Submission and Deadline

Submit the original and two copies of

PHS 5161–1 (OMB Number 0937–0189).

Forms are in the application kit. On or

before August 17, 1998, submit the

application to: Maggie Slay Warren,

Grants Management Specialist, Grants

Management Branch, Procurement and

Grants Office, Announcement 98098,

Centers for Disease Control and

Prevention (CDC), Room 300, 255 East

Paces Ferry Road, NE., M/S E–15,

Atlanta, Georgia 30305–2209.

If your application does not arrive in

time for submission to the independent

review group, it will not be considered

in the current competition unless you

can provide proof that you mailed it on

or before the deadline (i.e., receipt from

U.S. Postal Service or a commercial

carrier; private metered postmarks are

not acceptable).

G. Evaluation Criteria

Each application will be evaluated

individually against the following

criteria by an independent review group

appointed by CDC.

1. Behavioral Intervention (20 percent)

The applicant must clearly

demonstrate the effectiveness of the

proposed small-group or individuallevel intervention in a report that has

been submitted for publication or has

been published in a peer-reviewed

journal. This is an absolute criterion. If

this evidence is not present, score as

zero.

a. The intervention is directed to

small groups or individuals, especially

persons at increased risk of infection.

b. The applicant provides justification

if proposing to conduct the intervention

with any groups other than the initial

target population.

c. The applicant addresses the

feasibility of implementing the

prevention package by organizations

with limited resources.

2. Prevention Package (15 percent)

Level of detail in the description or

outline of the proposed package,

including materials, protocols, and

guidelines. Clarity of described format

and concepts; intended audiences; and

objectives. Justification of the

appropriateness of the package’s

objectives, format, and concepts to the

intended users’ needs and capabilities.

Adequacy of input from HIV prevention

programs into the development of the

package. Adequacy of planned

materials’ review, pretesting, and

revision of materials as needed.

Adequacy of time scheduled for

completing the proposed steps of the

package’s development.

3. Plan to Identify Field Site(s) to

Implement the Package (10 percent)

Quality of plan to identify appropriate

and eligible intended users and interest

them in adopting the package during

year 2 of the project. Selection of

proactive methods to identify and solicit

intended users. Adequacy of criteria and

mechanism for selecting the users for

implementing the package in year 2,

including match of the intervention’s

target population with the user’s

community planning priorities.

Recognition that the agency that

originally conducted the intervention is

excluded from implementing the

package.

4. Strategy to Assist Implementation (15

percent)

Clarity of the strategy to assist

selected users in adopting and

implementing the behavioral

intervention. Understanding of barriers

to implementation and how to overcome

them. Plan to assist selected users in

implementing the intervention by using

their existing resources and staff,

including provision of on-call technical

assistance. Plan to help selected users

find additional funds for implementing

the package, if relevant.

5. Plan to Evaluate Implementation

Process (15 percent)

Feasibility and appropriateness of the

applicant’s plan to evaluate the selected

user’s implementation of the

intervention as specified in the

replication package. Thorough and

realistic selection of process measures to

evaluate.

6. Demonstrated Capacity (15 percent)

Overall ability of the applicant to

perform the proposed activities as

reflected in their staff’s and consultants’

qualifications and availability. The

extent to which the applicant’s

demonstrates that proposed staff have

experience with material development

and dissemination and demonstrated

familiarity with HIV behavioral

interventions, in general, and the

intervention to be publicized, in

particular. The nature and extent of any

partnership between researchers and

HIV prevention programs. Adequacy of

existing support staff, equipment, and

facilities.

7. The degree to which the applicant has

met the CDC Policy requirements

regarding the inclusion of women,

ethnic, and racial groups in the

proposed research (10 percent)

This includes:

a. The proposed plan for the inclusion

of both women and racial and ethnic

minority populations for appropriate

representation.

b. The proposed justification when

representation is limited or absent.

c. A statement as to whether the

design of the study is adequate to

measure differences when warranted.

d. A statement as to whether the plans

for recruitment and outreach for study

participants include the process of

establishing partnerships with

communities and recognition of mutual

benefits.

8. Does the application adequately

address the requirements of Title 45

CFR Part 46 for the protection of human

subjects?

lllYES

lllNo

Comments:llllllllll

9. Budget (not scored)

Extent to which the budget is

reasonable, itemized, clearly justified,
Federal Register / Vol. 63, No. 132 / Friday, July 10, 1998 / Notices 37387

and consistent with the intended use of

the funds. Extent to which the budget

includes itemizations, justifications,

scope, and deliverables for consultants

or contractors.

H. Other Requirements

Technical Reporting Requirements

An original and two copies of semiannual progress reports are required.

Timelines for the semi-annual reports

will be established at the time of award.

Final financial status and performance

reports are required no later than 90

days after the end of the project period.

All reports are submitted to the Grants

Management Branch, CDC. At the completion of 2 years of

funding, recipients will be expected to

share prevention packages with

representatives of the original agencies

that conducted the interventions on

which the products are based, if

different from those of the recipient.

The following additional

requirements are applicable to this

program. For a complete description of

each, see Attachments.

AR98–1 Human Subjects

Requirements

AR98–2 Requirements for Inclusion of

Women, Racial and Ethnic

Minorities in Research

AR98–4 HIV/AIDS Confidentiality

Provisions

AR98–5 HIV Program Review Panel

Requirements

AR98–7 Executive Order 12373

Review

AR98–8 Public Health System

Reporting Requirements

AR98–9 Paperwork Reduction Act

Requirements

AR98–10 Smoke-Free Workplace

Requirements

AR98–11 Healthy People 2000

AR98–12 Lobbying Restrictions

I. Authority and Catalog of Federal

Domestic Assistance Number

This program is authorized under

sections 301 and 317(k), of the Public

Health Service Act [42 U.S.C. 241 and

247b], as amended. The Catalog of

Federal Domestic Assistance number is

93.941.

J. Where to Obtain Additional

Information

To receive additional written

information, call (888) 472-6874. You

will be asked to leave your name,

address, and telephone number. Please

refer to Program Announcement 98098

when you request information. For a

complete program description,

information on application procedures,

an application package, and business

management technical assistance,

contact: Maggie Slay Warren, Grants

Management Specialist, Grants

Management Branch, Procurement and

Grants Office Announcement 98098,

Centers for Disease Control and

Prevention (CDC), Room 300, 255 East

Paces Ferry Road, NE., M/S E–15,

Atlanta, GA 30305–2209 telephone

(404) 842–6797. Email address http://

www.MCS9@CDC.gov

See also the CDC home page on the

Internet: http://www.cdc.gov

For program technical assistance,

contact: Robert Kohmescher, Division of

HIV/AIDS Prevention, National Center

for HIV/STD/TB Prevention, Centers for

Disease Control and Prevention (CDC),

1600 Clifton Road, NE., Mailstop E–44,

Atlanta, GA 30333 telephone (404) 639–

8302 email: www.rnk1@cdc.gov

Please refer to Announcement number

98098 when requesting information and

submitting an application.

Dated: July 6, 1998.

John L. Williams,

Director, Procurement and Grants Office,

Centers for Disease Control and Prevention

(CDC).

[FR Doc. 98–18389 Filed 7–9–98; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Administration for Children and

Families

[Notice of Program Announcement No.

ACF/ACY/CB–98–05]

New Child Welfare Demonstration

Project Proposals Submitted by States

for Waivers Pursuant to Section 1130

of the Social Security Act (the Act);

Titles IV–E and IV–B of the Act; Public

Law 103–432

AGENCY: Administration for Children

and Families, HHS.

ACTION: Notice.

SUMMARY: This notice lists new

proposals for child welfare waiver

demonstration projects submitted to the

Department of Health and Human

Services pursuant to the guidance

contained in Information Memorandum

ACYF–CB–IM–98–01 dated February

13, 1998, public notice of which was

given in the Federal Register of March

4, 1998, Vol. 63, No. 42, page 10637.

COMMENTS: We will accept written

comments on these proposals, but will

not provide written responses to

comments. We will neither approve nor

disapprove any new proposal for at least

30 days after the date of this notice to

allow time to receive and consider

comments. Direct comments as

indicated below.

ADDRESSES: For specific information or

questions on the content of a project or

requests for copies of a proposal, contact

the State contact person listed for that

project.

Comments on a proposal should be

addressed to: Michael W. Ambrose,

Administration on Children, Youth and

Families, Children’s Bureau, 330 C

Street, SW, Mary E. Switzer Building,

Room 2058, Washington, D.C., 20201.

FAX: (202) 260–9345.

SUPPLEMENTARY INFORMATION:

I. Background

Under Section 1130 of the Social

Security Act (the Act), the Secretary of

Health and Human Services (HHS) may

approve child welfare waiver

demonstration project proposals with a

broad range of policy objectives.

In exercising her discretionary

authority, the Secretary has developed a

number of policies and procedures for

reviewing proposals. The most recent

expression of these policies and

procedures may be found in the

February 13, 1998 Information

Memorandum cited above, a copy of

which may be found at the ACF website

at http://www.acf.dhhs.gov/program/cb/

demonstrations or may be obtained from

the National Clearinghouse on Child

Abuse and Neglect Information, (800)

394–3366, internet address

<nccanch@calib.com>. We are

committed to a thorough and

expeditious review of state proposals to

conduct child welfare demonstrations.

II. Listing of New Proposals

As part of our procedures, we are

publishing a notice in the Federal

Register of all new proposals. This

notice contains summaries of 17

proposals received by April 30, 1998.

Each of the proposals contains an

assurance that the proposed

demonstration effort will be cost neutral

to the federal government over the life

of the proposed effort; and each

proposal contains an evaluation

component designed to assess the

effectiveness of the project.

State: Arkansas

Description: The State of Arkansas

proposes to use title IV–E funds to

enhance mental health services

available for children in foster care and

children at risk of being placed in foster

care, and thereby reduce barriers to

permanency for those children. The

State intends, in October, 1998, to

implement a system for mental health

managed care for all title XIX eligible

children, and all children in DCFS

foster care. Under this demonstration,

the State would use title IV–E funds to